![aTyr Pharma Inc](/common/images/company/N_LIFE.png)
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -55.048 | -56.755 | -48.578 | -53.08 | -43.314 | -43.78 | -42.909 | -46.562 |
Return on Equity (%) | -65.06 | -75.889 | -70.514 | -86.338 | -61.794 | -48.031 | -50.261 | -62.303 |
Return on Invested Capital (%) | -74.912 | -64.345 | -54.384 | -73.322 | -61.049 | -48.51 | -52.537 | -71.24 |
Operating Margin (%) | N/A | N/A | N/A | -5631.043 | -155.237 | N/A | -436.578 | -14276.771 |
Net Profit Margin (%) | N/A | N/A | N/A | -5593.128 | -155.179 | N/A | -436.53 | -14274.504 |
Book Value Per Share | 0.38 | 2.003 | 1.024 | 3.798 | 2.857 | 3.926 | 2.417 | 1.545 |
Earnings Per Share | -0.35 | -1.503 | -1.05 | -4.264 | -1.472 | -1.215 | -1.537 | -0.86 |
Cash Per Share | 0.232 | 0.658 | 0.699 | 1.664 | 1.538 | 0.084 | 0.338 | 0.385 |
Working Capital Per Share | 0.401 | 2.388 | 1.216 | 3.432 | 2.692 | 3.87 | 2.272 | 1.478 |
Operating Profit Per Share | N/A | N/A | N/A | 0.076 | 0.949 | N/A | 0.352 | 0.006 |
EBIT Per Share | -0.35 | -1.503 | -1.05 | -4.292 | -1.473 | -1.215 | -1.537 | -0.861 |
EBITDA Per Share | -0.35 | -1.503 | -1.05 | -4.292 | -1.473 | -1.215 | -1.537 | -0.861 |
Free Cash Flow Per Share | -0.351 | -1.484 | -1.055 | -4.364 | -1.506 | -1.225 | -1.489 | -0.799 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 23,75M | 29,79M | 30,58M | 3,89M | 11,02M | 27,79M | 29,5M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 29,5M | N/A | 57,05M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | -6590.213 | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | -6591.915 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 128,73M |
Ratio cours/bénéfice | -2,55 |
Ratio prix/ventes | 365,38 |
Ratio prix/liquidités | 5,71 |
Ratio prix/valeur comptable | 1,42 |
Rendement de dividende | - |
Actions en circulation | 67,75M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | - |
Plus haut sur 52 semaines | - |
Plus bas sur 52 semaines | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales